Prognostic Value of Next Generation Sequencing in the Evaluation of Minimal Residual Disease in Pediatric Acute Lymphoblastic Leukemia

被引:0
|
作者
Bozhinovkj, Elizabeta Krstevska [1 ]
Matevska-Geshkovska, Nadica [1 ]
Stojovska, Marija Staninova [1 ]
Teov, Bojan [2 ]
Jovanovska, Aleksandra [2 ]
Kocheva, Svetlana [2 ]
Dimovski, Aleksandar [1 ,3 ]
机构
[1] Univ Ss Cyril & Methodius Skopje, Ctr Biomol Pharmaceut Analy, Fac Pharm, Skopje, North Macedonia
[2] Univ Ss Cyril & Methodius Skopje, Univ Clin Childrens Dis, Fac Med, Skopje, North Macedonia
[3] Macedonian Acad Sci & Arts, Res Ctr Genet Engn & Biotechnol Georgi D Efremov, Skopje, North Macedonia
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
P13.114.B
引用
收藏
页码:584 / 585
页数:2
相关论文
共 50 条
  • [21] Next-generation sequencing in the diagnosis and minimal residual disease assessment of acute myeloid leukemia
    Levine, Ross L.
    Valk, Peter J. M.
    HAEMATOLOGICA, 2019, 104 (05) : 868 - 871
  • [22] NEXT-GENERATION-SEQUENCING BY 454 GS TECHNOLOGIES FOR MINIMAL RESIDUAL DETECTION IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA
    Salemi, D.
    Cannella, S.
    Randazzo, V.
    Agueli, C.
    Bica, M. G.
    Marfia, A.
    Lacerna, C. Russo
    Iacono, M.
    Messina, M.
    Fabbiano, F.
    Santoro, A.
    HAEMATOLOGICA, 2016, 101 : S47 - S47
  • [23] IMMUNE FUNCTION AND MINIMAL RESIDUAL DISEASE IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
    Thompson, Joel
    Auletta, Jeffery
    Muszynski, Jennifer
    Hall, Mark
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S33 - S33
  • [24] DNA Methylation Adds Prognostic Value to Minimal Residual Disease Status in Pediatric T-Cell Acute Lymphoblastic Leukemia
    Borssen, Magnus
    Haider, Zahra
    Landfors, Mattias
    Noren-Nystrom, Ulrika
    Schmiegelow, Kjeld
    Asberg, Ann E.
    Kanerva, Jukka
    Madsen, Hans O.
    Marquart, Hanne
    Heyman, Mats
    Hultdin, Magnus
    Roos, Goran
    Forestier, Erik
    Degerman, Sofie
    PEDIATRIC BLOOD & CANCER, 2016, 63 (07) : 1185 - 1192
  • [25] Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
    Matsumura, T
    Kami, M
    Saito, T
    Sakamaki, H
    Hirai, H
    LANCET, 1999, 353 (9154): : 752 - 752
  • [26] Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
    van Dongen, JJM
    Seriu, T
    Panzer-Grümayer, ER
    Biondi, A
    Pongers-Willemse, MJ
    Corral, L
    Stolz, F
    Schrappe, M
    Masera, G
    Kamps, WA
    Gadner, H
    van Wering, ER
    Ludwig, WD
    Basso, G
    de Bruijn, MAC
    Cazzaniga, G
    Hettinger, A
    van der Does-van den Berg, A
    Hop, WCJ
    Riehm, H
    Bartram, CR
    LANCET, 1998, 352 (9142): : 1731 - 1738
  • [27] Amplicon based next-generation-sequencing to quantify minimal residual disease in B-cell precursor acute lymphoblastic leukemia
    Koopmann, J.
    Knecht, H.
    Fuellgrabe, M.
    Pott, C.
    Goekbuget, N.
    Kneba, M.
    Brueggemann, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 212 - 212
  • [28] THE PREDICTIVE STRENGTH OF NEXT GENERATION SEQUENCING MINIMAL RESIDUAL DISEASE DETECTION FOR RELAPSE COMPARED WITH CURRENT METHODS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
    Kotrova, M.
    Muzikova, K.
    Mejstrikova, E.
    Novakova, M.
    Bakardjieva-Mihaylova, V.
    Fiser, K.
    Stuchly, J.
    Pott, C.
    Bruggemann, M.
    Stary, J.
    Trka, J.
    Fronkova, E.
    HAEMATOLOGICA, 2015, 100 : 156 - 157
  • [29] Next-Generation Sequencing of Minimal Residual Disease for Predicting Relapse after Tisagenlecleucel in Children and Young Adults with Acute Lymphoblastic Leukemia
    Pulsipher, Michael A.
    Han, Xia
    Maude, Shannon L.
    Laetsch, Theodore W.
    Qayed, Muna
    Rives, Susana
    Boyer, Michael W.
    Hiramatsu, Hidefumi
    Yanik, Gregory A.
    Driscoll, Tim
    Myers, G. Doug
    Bader, Peter
    Baruchel, Andre
    Buechner, Jochen
    Stefanski, Heather E.
    Kalfoglou, Creton
    Nguyen, Kevin
    Waldron, Edward R.
    Mueller, Karen Thudium
    Maier, Harald J.
    Kari, Gabor
    Grupp, Stephan A.
    BLOOD CANCER DISCOVERY, 2022, 3 (01): : 66 - 81
  • [30] Comprehensive Evaluation and Validation of a Next-Generation Sequencing Assay for Minimal Residual Disease Detection in T-Lymphoblastic Leukemia/Lymphoma
    Xu, Chang
    Studer, Ally
    Chen, Xueyan
    Hoyle, Eric
    Wu, David
    Mao, Zhengwei
    Wood, Brent L.
    BLOOD, 2019, 134